Analysts Set Henry Schein, Inc. (HSIC) Target Price at $81.50

Henry Schein, Inc. (NASDAQ:HSIC) has received an average rating of “Hold” from the twenty-three analysts that are currently covering the stock, MarketBeat reports. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and nine have issued a buy rating on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $84.00.

A number of brokerages have weighed in on HSIC. BidaskClub lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Friday. Leerink Swann set a $100.00 price target on shares of Henry Schein and gave the company a “buy” rating in a report on Tuesday, August 7th. Barrington Research reiterated a “buy” rating and issued a $92.00 price target on shares of Henry Schein in a report on Tuesday, August 7th. Craig Hallum lifted their price target on shares of Henry Schein from $83.00 to $96.00 and gave the company a “buy” rating in a report on Tuesday, August 7th. Finally, Robert W. Baird lifted their price target on shares of Henry Schein from $83.00 to $90.00 and gave the company an “outperform” rating in a report on Tuesday, August 7th.

Henry Schein traded down $1.16, reaching $77.37, during mid-day trading on Tuesday, according to MarketBeat. 1,026,832 shares of the stock were exchanged, compared to its average volume of 1,194,455. Henry Schein has a 1-year low of $62.56 and a 1-year high of $89.34. The firm has a market cap of $12.02 billion, a P/E ratio of 20.50, a price-to-earnings-growth ratio of 2.17 and a beta of 1.00. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.74 and a current ratio of 1.29.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Monday, August 6th. The company reported $1.04 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.01 by $0.03. Henry Schein had a net margin of 3.15% and a return on equity of 20.40%. The firm had revenue of $3.33 billion for the quarter, compared to analyst estimates of $3.31 billion. During the same quarter last year, the business earned $0.88 earnings per share. Henry Schein’s revenue was up 8.7% compared to the same quarter last year. equities analysts predict that Henry Schein will post 4.11 EPS for the current year.

In other news, Director Paul Brons sold 4,822 shares of the firm’s stock in a transaction on Monday, June 11th. The shares were sold at an average price of $72.93, for a total value of $351,668.46. Following the transaction, the director now owns 20,889 shares of the company’s stock, valued at approximately $1,523,434.77. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Mark E. Mlotek sold 10,359 shares of the firm’s stock in a transaction on Tuesday, June 12th. The shares were sold at an average price of $72.73, for a total transaction of $753,410.07. Following the completion of the transaction, the executive vice president now directly owns 79,506 shares in the company, valued at approximately $5,782,471.38. The disclosure for this sale can be found here. Company insiders own 1.15% of the company’s stock.

Several hedge funds have recently modified their holdings of HSIC. Commerce Bank boosted its holdings in shares of Henry Schein by 5.5% in the 1st quarter. Commerce Bank now owns 14,473 shares of the company’s stock valued at $973,000 after buying an additional 760 shares during the period. Fuller & Thaler Asset Management Inc. boosted its holdings in shares of Henry Schein by 57.1% in the 2nd quarter. Fuller & Thaler Asset Management Inc. now owns 2,200 shares of the company’s stock valued at $160,000 after buying an additional 800 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its holdings in shares of Henry Schein by 1.8% in the 2nd quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 46,794 shares of the company’s stock valued at $3,399,000 after buying an additional 846 shares during the period. BB&T Securities LLC boosted its holdings in shares of Henry Schein by 26.8% in the 1st quarter. BB&T Securities LLC now owns 4,676 shares of the company’s stock valued at $314,000 after buying an additional 988 shares during the period. Finally, Gabelli Funds LLC boosted its holdings in shares of Henry Schein by 0.3% in the 1st quarter. Gabelli Funds LLC now owns 332,300 shares of the company’s stock valued at $22,334,000 after buying an additional 1,100 shares during the period.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More: Earnings Per Share (EPS) Explained

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply